Research leading up to the ongoing phase 3 trial of SAGE-547, a potential drug for super-refractory status epilepticus, was presented at AAN 2016.
Videos
In this Medical News Minute, Dr Bobby Lazzara examines carotid-artery stenting vs. carotid endarterectomy to treat asymptomatic carotid stenosis.
Do you and your patients with epilepsy agree on treatment decisions? A national survey compares AED attribute preferences of patients and neurologists.
The chair of Allegheny Health Network’s Neurosciences Institute discussed a groundbreaking phase 3 trial evaluating the safety and efficacy of deep brain stimulation in patients with Alzheimer disease. [WATCH TIME: 5 minutes]
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Testing D1 Receptor Modulator Glovadalen in Phase 2 Trial for Parkinson Disease: Milton Biagioni MD, CMD
2
Mechanistic Rationale Behind Amlenetug to Treat Multiple System Atrophy: Johan Luthman, PhD
3
COAST Trial: Evaluating Ozanimod Step-Down in Multiple Sclerosis
4
Long-Term Management and Patient Engagement in Step-Down Strategies
5
